Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence

NCT ID: NCT00672256

Last Updated: 2014-07-23

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 62 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2007-01-31
• Study Completion Date: 2009-03-31

Brief Summary

The broad objective of this proposal is to identify functional neuroanatomical correlates of impairments in response inhibition during smoking abstinence. We will measure changes in performance and regional blood oxygenation levels using functional magnetic resonance imaging (fMRI)while smokers complete tasks designed to assess decision making and response inhibition.

Our primary hypothesis is that smoking abstinence will result in impaired response inhibition accompanied by decreases in blood-oxygenation-level-dependent (BOLD) fMRI signal in brain regions associated with these cognitive processes including frontal cortex and the ventral striatum. Abstinence may also result in performance-related increases in activation in brain regions associated with effortful processing including the anterior cingulate cortex in effort to compensate for deficits in other regions.

Detailed Description

Participants will learn and practice a Go/No-Go reaction time task (Garavan, Hester, Murphy, Fassbender, & Kelly, 2006) that measures inhibitory and excitatory aspects of behavioral control. During the task subjects are presented with an alternating series of Xs and Ys in the center of the screen and must press a button every time they see a Go trial (the letter 'Y' or the letter 'X') while inhibiting a response when they are presented with a No-Go trial (any interruption of the X Y alternating stream, e.g., X Y Y).

Conditions

Smoking

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: BASIC_SCIENCE
• Blinding Strategy: NONE

Study Groups

Smokers not interested in quitting smoking

Smokers were scanned 24 hours after quitting smoking, and scanned after smoking as usual.

Group Type: EXPERIMENTAL

Smoking Abstinence

Intervention Type: BEHAVIORAL

Smokers were scanned after having quitting smoking for 24 hours, and scanned after smoking as usual.

Interventions

Smoking Abstinence

Smokers were scanned after having quitting smoking for 24 hours, and scanned after smoking as usual.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

Smoker subjects must have

• smoked an average of 10 cigarettes per day for two continuous years of a brand that delivers (by Federal Trade Commission rated yields) at least 0.5 mg nicotine
• have an expired air carbon monoxide reading of at least 10 ppm.
• must be in general good health

Non-smoker subjects must have

• smoked less than 50 cigarettes in their lifetime
• have not smoked in the last six months
• have an expired air carbon monoxide reading of less than or equal to 5 ppm.
• must be in general good health.

Exclusion Criteria

• major medical condition
• anything that would make participation unsafe (e.g., have pacemaker or other metallic implant) or uncomfortable (e.g., chronic pain)
• psychiatric condition
• suffering from claustrophobia
• current alcohol or drug abuse
• smokeless tobacco use, or use of nicotine replacement therapy or other smoking cessation treatment

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 50 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

National Institutes of Health (NIH)

NIH

Sponsor Role: collaborator

Duke University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Francis J McClernon, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Duke University Medical Center

Durham, North Carolina, United States

Countries

United States

Other Identifiers

DA017261

Identifier Type: -

Identifier Source: secondary_id

9270

Identifier Type: OTHER

Identifier Source: secondary_id

Pro00011917

Identifier Type: -

Identifier Source: org_study_id